Comparison of Efficacy and Safety Outcomes of Different Doses Schedules of Thalidomide for Treating Moderate-to-Severe β-Thalassemia Patients

Yang WJ, Shi LD, Liang Y, Liang LM, Zhang H, Wang L, Zhou Q

Therapeutics and Clinical Risk Management 2024, 20:799-809

Published Date: 29 November 2024